I have followed the company for almost 7 years. During this entire time, Berger has claimed to be building a fully integrated pharmaceutical company. Scary since the company has no approved drugs.
Berger has a long history of
1. bullshit bingo starting with the phrase he applies to every Ariad compound that succeeds in a petri dish - "best in class"
2. over-promising and under-delivering on clinical deadlines and partnerships
3. overseeing a revolving door of industry hires ostensibly added to bring structure and process to the organization
4. running the company as an R&D lab
The current Phase 3 in sarcomas is a test of one's investing philosophies -
Are Merck and the SPA which it helped negotiate legitimizing factors which warrant a long position? or
Does the fact that the SPA requires 27511 to demonstrate efficacy beyond the Phase 2 results preclude investment?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.